RECORD | Already taken place We, 23.6.2021
Chris Henry will be showcasing the ease of use of the Acquity RDa in relation to forced degradation. Forced degradation studies are vital for developing a new small molecule drug. Go to the webinar
Meet the Experts - Part 4 - Access Accurate Mass with a SmartMS Enabled Mass Detector for Forced Degradation Studies
StartupStockPhotos: Waters Corporation - Meet the Experts Webinars
These studies play an important role in the development of analytical methods, setting specifications, and designing the formulation of new therapeutic.
Presenter: Christopher Henry (Senior Scientist, Waters Corporation)
Chris has been at Waters for 8 years working in the area of small molecule pharma solutions using LC-MS.
Prior to joining Waters Chris has worked in industry for 20 years focussing on late-stage development and QC.
He obtained a degree in Biochemistry from the University of Paisley.
